Lifestyle Medicine and Cancer in Viet Nam: Prevention, Supportive Care and Survivorship
EVIDENCE & CLINICAL PRACTICELIFESTYLE MEDICINE IN VIET NAM


Lifestyle Medicine and Cancer in Viet Nam: Prevention, Supportive Care and Survivorship
Last reviewed: November 7, 2026
Cancer is one of the areas where Lifestyle Medicine can make a meaningful contribution, but also where its clinical boundaries must be particularly clear.
Tobacco use, alcohol consumption, excess body weight, physical inactivity and dietary patterns influence the risk of several cancers. After a cancer diagnosis, appropriate nutrition, physical activity, sleep support, psychological care and social connection may help patients maintain function, manage symptoms and improve quality of life.
However, cancer is not one disease, and lifestyle interventions do not have the same role at every stage.
The needs of a healthy person seeking to reduce cancer risk are very different from those of someone receiving chemotherapy, experiencing unintended weight loss or living with advanced cancer. Recommendations that are appropriate for prevention may become unsuitable or even harmful during active treatment.
Lifestyle Medicine should therefore be understood within the wider cancer-care continuum, alongside vaccination, screening, timely diagnosis, tumor-directed treatment, supportive care, rehabilitation, palliative care and long-term follow-up.
Its role is to complement appropriate cancer care, never to replace or delay it.
For Viet Nam, this distinction matters as healthcare organizations increasingly explore how evidence-based lifestyle interventions can contribute to prevention and clinical services.
Understanding the Cancer Burden in Viet Nam
Cancer remains a major health challenge in Viet Nam.
The International Agency for Research on Cancer's GLOBOCAN 2024 estimates, released in July 2026, provide the latest internationally comparable national figures available for this review.
According to these estimates, Viet Nam had approximately 177,404 new cancer cases and 111,015 cancer deaths in 2024. An estimated 404,153 people were living within five years of a cancer diagnosis.
The three most commonly diagnosed cancers overall were breast cancer, with 25,711 new cases; lung cancer, with 23,085; and colorectal cancer, with 22,584. Lung cancer was the leading cause of cancer death, followed by liver and colorectal cancers. [1]
These figures are modeled estimates, not a complete national cancer registry count. They should also not be directly compared with earlier GLOBOCAN estimates to infer trends without accounting for changes in population, data availability and estimation methods.
The five-year prevalence figure does not represent everyone living with or after cancer. People diagnosed more than five years earlier may also require ongoing care.
Nevertheless, these estimates illustrate the considerable demand for cancer prevention, diagnosis, treatment and long-term support.
The World Health Organization's Global Status Report on Cancer 2026, published in July, places this challenge in a wider context. The report examines progress and persistent gaps across prevention, early detection, diagnosis, treatment, palliative care and survivorship. It emphasizes that scientific advances can only improve population outcomes when effective services are accessible, affordable and integrated into health systems. [2]
Lifestyle Medicine has a potential role throughout this continuum, but that role changes according to the person's clinical situation.
Three Different Contexts for Lifestyle Medicine in Cancer
It is useful to distinguish three overlapping areas of care.
Cancer prevention focuses on reducing modifiable risk factors before cancer develops. This includes tobacco prevention and cessation, reducing alcohol exposure, appropriate weight management, healthy dietary patterns and regular physical activity.
Supportive care during cancer treatment focuses on helping patients tolerate treatment, maintain nutritional status and physical function, manage symptoms, address psychological and social needs, and preserve quality of life. These interventions must be coordinated with the oncology team and adapted to the patient's condition.
Cancer survivorship begins at diagnosis and continues throughout life. It includes people receiving treatment, those living with cancer and those who have completed treatment. Long-term priorities may include recovery, ongoing cancer surveillance, managing treatment-related effects, reducing other chronic disease risks and supporting meaningful participation in everyday life.
These areas are related but should not be treated as interchangeable.
For someone without cancer, achieving and maintaining a healthy weight may be an appropriate prevention goal.
For someone undergoing chemotherapy who is experiencing poor appetite and substantial unintended weight loss, restricting calories to achieve weight loss may be dangerous.
For a person recovering after treatment, the priority may be to rebuild strength and functional capacity rather than immediately pursue general population exercise targets.
The same lifestyle intervention can therefore have different implications depending on when and for whom it is recommended.
Cancer Prevention Is Broader Than Lifestyle Medicine
A major analysis published in Nature Medicine in February 2026 estimated that approximately 37.8% of new cancer cases worldwide in 2022 were attributable to 30 modifiable risk factors.
These included tobacco, alcohol, excess body weight, insufficient physical activity, carcinogenic infections, air pollution, ultraviolet radiation and occupational exposures.
Tobacco was the largest single contributor, followed by cancer-causing infections and alcohol. [3]
This is an important finding, but it requires careful interpretation.
The estimate refers to the global cancer burden in 2022 and should not be applied directly as a percentage of cancer cases in Viet Nam. It also does not mean that every cancer associated with a modifiable risk factor can be prevented through individual behavior change alone.
Cancer prevention requires a combination of individual, clinical, community and population-level interventions.
Vaccination against hepatitis B and human papillomavirus, appropriate screening, identification and treatment of precancerous lesions, control of occupational carcinogens and reduction of harmful environmental exposures are essential components of comprehensive cancer prevention.
In Viet Nam, hepatitis-related liver disease and cancers associated with human papillomavirus make infection prevention particularly relevant.
The World Health Organization published updated guidance on human papillomavirus DNA genotyping for cervical cancer screening in May 2026, followed by implementation guidance for human papillomavirus-based screening programs in July 2026. [4,5]
These developments reinforce the importance of prevention strategies supported by strong evidence and adapted to available healthcare resources.
Lifestyle Medicine should therefore be positioned as one contributor to cancer prevention, not as a replacement for vaccination, screening or other established interventions.
Tobacco, Alcohol, Nutrition and Physical Activity in Cancer Prevention
The relationship between tobacco use and cancer is particularly well established.
Tobacco exposure contributes to lung cancer and cancers at several other sites. Preventing tobacco use and supporting cessation remain among the most important measures for reducing preventable cancer risk.
Tobacco cessation is also relevant after a cancer diagnosis. Continuing to smoke may adversely affect treatment, recovery and other health outcomes.
However, tobacco dependence should not be treated simply as a failure of willpower. Some patients require structured behavioral interventions and, when clinically appropriate, pharmacological treatment.
Alcohol is another established carcinogen. The World Cancer Research Fund recommends avoiding alcohol for cancer prevention, recognizing that even relatively low consumption can increase the risk of certain cancers. [6]
Excess adiposity is associated with an increased risk of several cancers, while regular physical activity is associated with reduced risk of some cancers.
Cancer-prevention recommendations also emphasize dietary patterns containing vegetables, fruit, whole grains and legumes, while limiting processed meat, sugar-sweetened beverages and other foods that contribute to unhealthy dietary patterns.
These recommendations concern the overall pattern of behavior across the life course. They do not establish that any particular food can prevent or cure cancer.
For Viet Nam, healthy eating should remain culturally relevant and affordable. Appropriate dietary patterns can be developed using familiar local foods without requiring expensive imported products or highly restrictive menus.
The objective is to support sustainable behaviors rather than promote a particular food as an anticancer remedy.
The language used in cancer prevention also matters.
A person who develops cancer despite avoiding tobacco, maintaining a healthy weight and remaining physically active has not failed at prevention.
Cancer involves multiple biological, genetic, infectious, environmental and other determinants. At the individual level, the cause of a particular cancer usually cannot be assigned to one behavior with certainty.
Prevention should empower people and improve their opportunities for health, not create blame or stigma.
Healthy Living Does Not Replace Screening or Early Diagnosis
People who follow healthy lifestyles can still develop cancer.
For this reason, lifestyle interventions must never be presented as substitutes for appropriate cancer screening or the timely investigation of concerning symptoms.
Screening recommendations depend on the cancer type, age, individual risk factors, family history and relevant national or professional guidance.
A person with unexplained weight loss, abnormal bleeding, a new or enlarging mass, persistent changes in bowel habits or other concerning symptoms may require medical assessment and diagnostic investigations.
Such symptoms should not simply be attributed to diet, stress or an unhealthy lifestyle.
A trial of supplements, fasting, dietary modification or other wellness interventions should not delay diagnostic evaluation.
For cancers in which early detection can meaningfully improve outcomes, unnecessary delays may reduce opportunities for effective treatment.
Lifestyle Medicine can help reduce some cancer risks, but it cannot guarantee prevention and must never delay appropriate screening, diagnosis or treatment.
During Cancer Treatment, Clinical Priorities Change
A cancer diagnosis changes the context in which lifestyle recommendations are made.
During surgery, systemic anticancer therapy, radiotherapy or other tumor-directed treatment, the immediate priorities may include treatment safety, nutritional adequacy, control of symptoms, preservation of physical function and the patient's ability to complete clinically indicated care.
Interventions should be selected according to cancer type, stage, treatment regimen, comorbidities, functional capacity and the individual's goals.
A patient receiving treatment may experience nausea, vomiting, diarrhea, mouth sores, changes in taste, swallowing difficulties, fatigue or reduced appetite.
Others may develop anemia, neutropenia, thrombocytopenia, peripheral neuropathy or substantial muscle loss.
These problems require clinical assessment and appropriate management. They should not be approached as ordinary lifestyle barriers that can necessarily be overcome through motivation or healthier habits.
The American Society of Clinical Oncology's 2022 guideline on exercise, diet and weight management during cancer treatment provides an important distinction.
For appropriately selected adults receiving treatment with curative intent, aerobic and resistance exercise can improve fatigue, strength, cardiorespiratory fitness and physical function.
However, the guideline found insufficient evidence to recommend specific dietary patterns, fasting or intentional weight loss during active treatment for improving cancer outcomes. [7]
This distinction is central to safe Lifestyle Medicine.
An intervention that has potential preventive benefits does not automatically improve cancer treatment outcomes.
Clinical Safety Checkpoint: Do Not Delay Cancer Care
Unintended weight loss and malnutrition
Unintentional weight loss, declining food intake, difficulty swallowing, persistent vomiting, muscle loss or suspected cancer cachexia require timely assessment. Patients should not be encouraged to pursue calorie restriction, prolonged fasting or weight-loss diets when nutritional adequacy is already compromised. Clinical nutrition assessment and appropriate supportive intervention may be necessary.
Fever and possible infection
Fever during chemotherapy can indicate a serious infection, including in patients with neutropenia. The United States Centers for Disease Control and Prevention advises patients receiving chemotherapy to contact their treating team immediately if their temperature reaches 38°C (100.4°F) or higher. Other signs of possible infection, including chills or sudden clinical deterioration, also warrant urgent attention. Patients should follow their oncology service's specific emergency instructions and should not wait for a routine appointment.
Treatment-related side effects
Severe or persistent vomiting, diarrhea, dehydration, inability to eat or drink adequately, unusual bleeding, significant breathlessness, chest pain, confusion or other concerning changes require clinical assessment according to their severity. These problems should not be managed solely through dietary advice, exercise, supplements or stress-management techniques.
Scheduled oncology treatment
Lifestyle interventions, including restrictive diets, fasting, supplements and exercise programs, must not independently delay, interrupt, replace or alter medically indicated cancer treatment. Decisions about cancer therapy, treatment toxicity, dose modification and scheduling remain the responsibility of the authorized oncology team.
This safety checkpoint is intended to emphasize clinical priorities, not to create a new cancer-treatment protocol. Patients should receive clear instructions from their treating service about warning signs, emergency contact arrangements and when to seek immediate care.
The principle is straightforward: supportive lifestyle care must fit around safe cancer treatment, not the other way around.
Nutrition During Treatment: Adequacy Comes Before Restriction
Nutrition is one of the areas where recommendations for cancer prevention and active treatment can differ most substantially.
For a generally healthy adult, reducing excess energy intake or improving dietary quality may be appropriate.
For a patient experiencing treatment-related anorexia, nausea, mucositis, malabsorption or unintended weight loss, the immediate nutritional goal may instead be to maintain adequate intake, preserve muscle mass and prevent further deterioration.
The European Society for Clinical Nutrition and Metabolism's practical guideline on clinical nutrition in cancer recommends evaluating nutritional intake, weight change and body mass index beginning at diagnosis and repeating assessment according to the person's clinical stability. [8]
When screening identifies nutritional risk, further assessment should consider food intake, symptoms affecting eating, muscle mass, physical performance and relevant clinical factors.
This is important because cancer-related malnutrition can occur even when a patient does not appear underweight.
Substantial muscle loss may be present in people with a normal or elevated body mass index. Relying only on current weight can therefore overlook clinically important deterioration.
Cancer cachexia requires particular attention. It is a complex syndrome involving metabolic and inflammatory processes, often associated with loss of skeletal muscle and sometimes loss of fat.
It cannot simply be corrected by telling a patient to eat more.
Management may require coordinated nutritional, medical, rehabilitative, psychological and palliative support, depending on the person's condition and goals.
The American Society of Clinical Oncology's guideline on cancer cachexia emphasizes individualized dietary counseling and appropriate supportive care while acknowledging limitations in the evidence for many specific interventions. [9]
Highly restrictive diets, prolonged fasting and unproven detoxification programs should not be promoted as anticancer treatments.
A plant-predominant diet may be appropriate for many people, but the principle should not become a rigid requirement that interferes with adequate protein and energy intake during treatment.
A patient struggling to maintain weight may need a wider range of tolerable, nutrient-dense foods, including foods that would not ordinarily be emphasized in a weight-loss program.
There is also a distinction between food safety and unnecessarily restrictive diets.
Some cancer treatments increase susceptibility to infection, making careful food handling and preparation important. However, the American Society of Clinical Oncology guideline does not recommend routine neutropenic diets that exclude raw fruit and vegetables as a method of preventing infection.
Appropriate food safety should focus on safe preparation, handling, storage and the patient's particular clinical circumstances, rather than automatically excluding large groups of nutritious foods.
For patients, eating well during cancer treatment often means eating enough, managing symptoms that interfere with intake and receiving appropriate professional support.
Food should help sustain treatment and recovery, not become an additional source of nutritional risk or pressure.
Exercise Can Be Beneficial, but It Must Be Clinically Appropriate
Physical activity has an established role in cancer supportive care and survivorship.
For appropriately selected patients, exercise can help preserve physical function, strength, cardiovascular fitness and quality of life. It can also reduce cancer-related fatigue and some other treatment-related symptoms.
However, recommending exercise during cancer treatment requires more than applying general population guidelines.
A person's cancer type, treatment phase, baseline capacity, blood counts, bone health, cardiovascular status, neurological symptoms and other clinical considerations may influence the appropriate intervention.
For someone receiving curative treatment who is medically stable, an individualized aerobic and resistance exercise program may be beneficial.
For a person with painful bone metastases, severe anemia, significant neuropathy, recent major surgery or substantial treatment toxicity, exercise may need modification, specialist assessment or temporary deferral.
The objective may be to preserve safe mobility, independence and everyday function rather than increase fitness.
The American Society of Clinical Oncology's exercise recommendations during active cancer treatment are supported by evidence of improvements in fatigue and physical functioning. They should not be interpreted as a requirement for every patient to meet identical exercise targets. [7]
Rehabilitation may involve physicians, physical therapists, other rehabilitation professionals and appropriately qualified exercise specialists working within their respective professional scopes.
Patients should also be reassessed as treatment progresses because their physical capacity and safety considerations can change.
A plan that was appropriate before chemotherapy, surgery or radiotherapy may need adjustment afterward.
Exercise should support cancer care rather than create avoidable injuries, exhaustion or delays in treatment.
Supportive Care Includes Fatigue, Sleep, Psychological Health and Social Needs
Cancer affects more than physical health.
Fatigue, disturbed sleep, pain, anxiety, depression, cognitive difficulties and changes in social participation may occur during treatment and persist afterward.
Cancer-related fatigue deserves particular attention because it can substantially affect daily functioning.
The 2024 American Society of Clinical Oncology and Society for Integrative Oncology guideline update supports interventions such as appropriately selected exercise, cognitive behavioral therapy and mindfulness-based approaches for managing cancer-related fatigue in relevant patient groups. [10]
These interventions may improve symptoms or quality of life. They should not be interpreted as evidence that psychological interventions or mindfulness treat the underlying cancer.
Persistent fatigue also requires clinical assessment when appropriate. Anemia, nutritional problems, sleep disorders, medication effects, depression and other conditions may contribute.
Sleep advice should similarly consider the cause of the problem. Pain, treatment schedules, medications, hot flashes, anxiety and sleep disorders may all affect sleep and require different responses.
Psychological support is important, but it should be offered without suggesting that cancer is caused by negative thinking or that recovery depends on maintaining a positive attitude.
Social and family support can also influence the experience of cancer.
In Viet Nam, family members frequently contribute to caregiving, transportation, communication with healthcare professionals and financial decisions.
These relationships may provide substantial support, but they can also involve caregiver burden, financial pressure and differences in preferences about treatment or communication.
Person-centered care should recognize the needs of both patients and families while respecting the patient's autonomy, preferences and confidentiality.
Lifestyle Medicine can contribute to whole-person supportive care, but it should remain connected to appropriate psychological, social-work, rehabilitation and palliative services when those services are needed.
Survivorship Begins at Diagnosis and Continues Beyond Treatment
Cancer survivorship is sometimes understood as the period after active treatment ends.
However, the United States National Cancer Institute defines a cancer survivor as a person from the time of diagnosis through the remainder of life. [11]
This broader definition recognizes that supportive and long-term needs may begin during treatment and continue for many years.
Some people live without evidence of cancer after completing treatment. Others continue receiving treatment or live with cancer as a chronic or advanced condition.
The needs of these groups differ.
Long-term consequences of cancer and its treatment may include fatigue, neuropathy, cardiovascular problems, reduced physical capacity, metabolic changes, cognitive difficulties, bone-health concerns and psychological distress.
Patients may also remain at risk of recurrence, second cancers or other chronic diseases.
The American Cancer Society's 2022 guideline on nutrition and physical activity for cancer survivors emphasizes early nutritional assessment, appropriate physical activity and attention to muscle preservation, dietary quality and other health risks. [12]
These recommendations should be individualized according to cancer type, treatment history, ongoing symptoms and comorbidities.
Survivorship care also requires continued oncology follow-up where indicated.
Lifestyle interventions do not replace surveillance for recurrence, assessment of late treatment effects or appropriate screening for other cancers.
Instead, they may complement these services by supporting functional recovery and management of cardiovascular, metabolic and other health risks.
New Evidence on Exercise and Cancer Outcomes Requires Careful Interpretation
One of the most important recent developments in cancer survivorship is the publication of stronger evidence concerning structured exercise after treatment for selected patients.
In 2025, the randomized phase III CHALLENGE trial, published in The New England Journal of Medicine, evaluated a three-year structured exercise program among patients with resected colon cancer who had completed adjuvant chemotherapy.
The trial reported improved disease-free survival in the exercise group compared with the health-education group.
At five years, estimated disease-free survival was 80.3% in the structured exercise group compared with 73.9% in the comparison group. The findings also supported a possible overall survival benefit, although interpretation should remain consistent with the study's outcomes and statistical analysis. [13]
The results are clinically important because they provide randomized evidence of a potential cancer-outcome benefit in a defined patient population, beyond the established benefits of exercise for physical function and quality of life.
In January 2026, the European Society for Medical Oncology published an express guideline update concerning the adoption of physical exercise in patients with localized colon cancer.
The guidance recommends informing eligible patients with resected stage III or high-risk stage II colon cancer about the available evidence and considering participation in structured exercise programs following appropriate assessment and shared decision-making. [14]
These findings should not be generalized to all patients with cancer.
The CHALLENGE trial evaluated a particular population after surgery and adjuvant chemotherapy, using a supported exercise intervention delivered over an extended period.
Its findings do not establish that any exercise program improves survival for every cancer type, stage or treatment situation.
They also do not justify replacing or delaying standard oncology treatment.
For Viet Nam, the trial provides a relevant example of how appropriately selected lifestyle interventions may contribute to evidence-based survivorship care.
The next question is how such interventions can be delivered safely and feasibly within existing oncology and rehabilitation services.
Advanced Cancer Requires Different Goals
People living with advanced cancer may have priorities that differ substantially from those of people seeking primary prevention or recovering after curative treatment.
For some, the main goals may be symptom control, maintaining independence, preserving mobility, managing nutritional difficulties or spending meaningful time with family.
Weight loss may result from cancer cachexia rather than a need for weight management. Fatigue and reduced physical capacity may reflect disease progression or treatment toxicity.
A rigid exercise or dietary program may therefore be inappropriate.
The value of a supportive intervention depends on whether it contributes to the person's comfort, functioning and chosen goals.
Palliative care is an essential component of comprehensive cancer care and should not be confused with abandoning treatment.
It can be introduced alongside disease-directed treatment and may address pain, other symptoms, psychological and social needs, communication, decision-making and quality of life.
The World Health Organization's Global Status Report on Cancer 2026 explicitly includes palliative care within the cancer continuum. [2]
Lifestyle-related support may contribute when it is clinically appropriate, but it should never delay specialist symptom management or palliative care.
In some situations, encouraging additional physical activity may be useful. In others, conserving energy, managing symptoms and maintaining comfort may be more important.
The patient's goals should guide the approach.
Integrating Lifestyle Medicine Into Cancer Care in Viet Nam
Lifestyle Medicine does not require every hospital to establish a separate oncology lifestyle clinic.
For many Vietnamese healthcare organizations, a more practical approach is to strengthen existing cancer-care pathways.
At diagnosis, appropriate assessment may identify tobacco exposure, nutritional risk, physical limitations, psychological distress and other needs that could affect care.
During treatment, these assessments can inform timely referrals to clinical nutrition, rehabilitation, smoking-cessation support, mental health services, social work or palliative care.
Supportive interventions should remain coordinated with the oncology treatment plan.
After treatment, survivorship services can address functional recovery, chronic disease risk, long-term treatment effects and return to work, family responsibilities and other meaningful activities.
Communication among oncology, rehabilitation, nutrition, primary care and other services is particularly important.
A patient should not receive conflicting recommendations about diet, activity or treatment from professionals working independently.
The organization should also establish clear processes for identifying clinical deterioration and ensuring that concerning symptoms are evaluated promptly.
International professional collaboration may support this work.
In 2026, the Multinational Association of Supportive Care in Cancer endorsed the American College of Lifestyle Medicine's Cancer Risk Reduction and Survivorship Toolkit.
The endorsement reflects growing interest in accessible, evidence-based lifestyle resources for cancer supportive care and survivorship. It should not be interpreted as endorsement of Lifestyle Medicine as an alternative anticancer treatment. [15]
For Viet Nam, the most valuable approach is likely to be integration into existing oncology services, supported by appropriate education, multidisciplinary coordination and local evaluation.
Prevention and Survivorship Must Remain Equitable
Healthy behaviors are influenced by social and environmental circumstances.
Food affordability, work schedules, housing, transportation, health literacy, air quality, healthcare access and financial resources all affect what patients can realistically do.
These factors are especially important during cancer treatment, when people may experience reduced income, increased family responsibilities and substantial out-of-pocket expenses.
A recommendation that assumes access to expensive foods, private rehabilitation services or frequent consultations may be feasible for some patients but unrealistic for others.
For Viet Nam, interventions should therefore be adapted to local resources and the patient's living circumstances.
Appropriate nutrition does not necessarily require imported foods. Physical activity support does not always require a specialized fitness facility. Psychological and social support may involve available community resources when suitable.
However, adaptation should not be confused with replacing necessary specialist care with lower-cost alternatives that lack evidence or clinical authorization.
Equity requires improving access to effective care, not lowering the standard of evidence.
The objective should be to make appropriate prevention, supportive care and survivorship services more accessible without creating additional financial or treatment burdens.
What Should Healthcare Organizations Measure?
The contribution of Lifestyle Medicine to cancer care should be evaluated through meaningful outcomes rather than the number of educational sessions or lifestyle recommendations delivered.
During active treatment, useful measures may include nutritional risk identification, unintended weight loss, changes in muscle mass where clinically relevant, physical functioning, fatigue, psychological well-being and patient-reported quality of life.
Healthcare organizations may also monitor whether appropriate referrals occur, whether patients receive timely supportive care and whether treatment-related problems are recognized and managed.
In survivorship, outcomes may include functional recovery, physical activity, dietary quality, tobacco cessation, cardiovascular and metabolic risk, return to work or social participation, and adherence to appropriate oncology follow-up.
Patient safety and treatment burden should be considered alongside potential benefits.
Cancer recurrence, cancer-specific survival and overall survival are important outcomes, but evaluating them requires appropriate study designs, sufficient follow-up and careful consideration of cancer type, stage, treatment and other influencing factors.
An improvement in fatigue or physical fitness should not automatically be described as evidence of reduced recurrence or increased survival.
Similarly, a program that achieves weight loss should not be considered successful if the patient was already at nutritional risk.
The most appropriate outcomes depend on the clinical objective and the patient's condition.
In prevention, that may mean reducing exposure to carcinogenic risk factors.
During active treatment, it may mean maintaining adequate nutrition, preserving function or reducing symptom burden.
In survivorship, it may mean improved long-term health, function and quality of life, alongside appropriate surveillance and medical care.
Vietnamese Law and Professional Responsibilities
Viet Nam's Law on Disease Prevention No. 114/2025/QH15, adopted on December 10, 2025 and effective July 1, 2026, provides a broader legal framework for disease prevention, including noncommunicable disease risk factors, preventive nutrition and relevant community-based activities.
Decree No. 165/2026/NĐ-CP, effective July 1, 2026, provides further implementation provisions. [16,17]
These developments support greater attention to prevention and risk-factor management.
However, they do not establish Lifestyle Medicine as an independent licensed medical profession or authorize cancer diagnosis or treatment outside existing healthcare regulations.
The Law on Medical Examination and Treatment, reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, remains central to regulated clinical practice. [18]
Cancer diagnosis, staging, treatment planning, systemic anticancer therapy, radiotherapy, surgery and other medical services must be undertaken by appropriately qualified and authorized professionals within the licensed activities of healthcare facilities.
The same principle applies to clinical supportive care.
Nutrition treatment, rehabilitation, psychological intervention and other regulated healthcare activities must remain within the applicable qualifications, competence and professional scopes of the practitioners involved.
International Lifestyle Medicine education, membership or certification does not independently create a Vietnamese medical practice license or expand professional authority.
Professional education platforms can help translate scientific evidence and encourage collaboration, but they should not represent educational recommendations as authorization to provide cancer treatment.
This distinction is essential for protecting patients and maintaining scientific credibility.
From Prevention to Survivorship, the Goal Is Better Cancer Care
Lifestyle Medicine has a meaningful potential contribution across the cancer continuum, but that contribution must be understood according to clinical context.
Before cancer develops, appropriate lifestyle interventions can help reduce certain preventable risks alongside vaccination, screening and broader public health measures.
During cancer treatment, the priority is supportive care that protects nutritional status, physical function, psychological health and quality of life without interfering with effective oncology treatment.
For people living with or after cancer, individualized interventions may support rehabilitation, long-term health, management of treatment-related effects and meaningful daily functioning.
For patients with advanced disease, supportive strategies should reflect their symptoms, goals and preferences, with timely access to appropriate palliative care.
Recent research, including the CHALLENGE trial and subsequent European Society for Medical Oncology guidance, demonstrates that the evidence for selected lifestyle interventions continues to evolve.
However, scientific progress should lead to more precise clinical recommendations, not broader claims that all lifestyle interventions improve cancer outcomes.
For Viet Nam, the opportunity is to strengthen the connections among prevention, oncology, clinical nutrition, rehabilitation, primary care, supportive care and survivorship.
Lifestyle Medicine should not be positioned as another cancer treatment competing with surgery, systemic therapy or radiotherapy. Its value lies in helping patients receive more comprehensive, evidence-based and person-centered care.
That means recognizing when lifestyle changes can help, when they need modification and when medical assessment or treatment must take priority.
Ultimately, responsible Lifestyle Medicine in cancer care is not about persuading every patient to follow an ideal lifestyle.
It is about supporting the right intervention, for the right person, at the right stage of care, without compromising safety or delaying effective cancer treatment.
References and Further Reading
International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. Viet Nam Fact Sheet, GLOBOCAN 2024. Lyon: International Agency for Research on Cancer; July 2026.
World Health Organization. Global Status Report on Cancer 2026: The Future We Choose Together. Geneva: World Health Organization; July 8, 2026.
Fink H, Langselius O, Vignat J, et al. Global and Regional Cancer Burden Attributable to Modifiable Risk Factors to Inform Prevention. Nature Medicine. 2026;32:1306–1315. doi:10.1038/s41591-026-04219-7.
World Health Organization. WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention: Use of Human Papillomavirus DNA Genotyping. Geneva: World Health Organization; May 8, 2026.
World Health Organization. Evidence-informed Guidance for the Implementation of HPV-based Cervical Cancer Screening Programmes. Geneva: World Health Organization; July 14, 2026.
World Cancer Research Fund International. Cancer Prevention Recommendations. London: World Cancer Research Fund International.
Ligibel JA, Bohlke K, May AM, et al. Exercise, Diet, and Weight Management During Cancer Treatment: American Society of Clinical Oncology Guideline. Journal of Clinical Oncology. 2022;40(22):2491–2507. doi:10.1200/JCO.22.00687.
Muscaritoli M, Arends J, Bachmann P, et al. ESPEN Practical Guideline: Clinical Nutrition in Cancer. Clinical Nutrition. 2021;40(5):2898–2913. doi:10.1016/j.clnu.2021.02.005.
Roeland EJ, Bohlke K, Baracos VE, et al. Management of Cancer Cachexia: American Society of Clinical Oncology Guideline. Journal of Clinical Oncology. 2020;38(21):2438–2453. doi:10.1200/JCO.20.00611.
Bower JE, Lacchetti C, Alici Y, et al. Management of Fatigue in Adult Survivors of Cancer: American Society of Clinical Oncology–Society for Integrative Oncology Guideline Update. Journal of Clinical Oncology. 2024;42(20):2456–2487. doi:10.1200/JCO.24.00541.
National Cancer Institute. Cancer Survivorship. U.S. National Institutes of Health.
Rock CL, Thomson CA, Sullivan KR, et al. American Cancer Society Nutrition and Physical Activity Guideline for Cancer Survivors. CA: A Cancer Journal for Clinicians. 2022;72(3):230–262. doi:10.3322/caac.21719.
Courneya KS, Vardy JL, O'Callaghan CJ, et al. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. New England Journal of Medicine. 2025;393(1):13–25. doi:10.1056/NEJMoa2502760.
Pentheroudakis G, Argilés G, Arnold D, Smyth E, Ducreux M. European Society for Medical Oncology Clinical Practice Guideline Express Update on the Adoption of Physical Exercise in Patients With Localised Colon Cancer. ESMO Open. 2026;11(2):106019. doi:10.1016/j.esmoop.2025.106019.
Ginex PK, Kleckner AS, Mansfield S, et al. Promoting Lifestyle Medicine for Supportive Care in Cancer: MASCC Endorsement of the ACLM Cancer Risk Reduction and Survivorship Toolkit. Supportive Care in Cancer. 2026;34(2):125. doi:10.1007/s00520-026-10367-w.
National Assembly of Viet Nam. Law on Disease Prevention No. 114/2025/QH15. Adopted December 10, 2025; effective July 1, 2026.
Government of Viet Nam. Decree No. 165/2026/NĐ-CP Detailing and Guiding Implementation of Selected Provisions of the Law on Disease Prevention. May 15, 2026; effective July 1, 2026.
Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH, Law on Medical Examination and Treatment. February 26, 2026.
World Health Organization. Cancer. Fact sheet updated July 3, 2026.
United States Centers for Disease Control and Prevention. Watch Out for Fever: Preventing Infections in Cancer Patients. Reviewed November 14, 2024.
National Cancer Institute. Nutrition During Cancer. U.S. National Institutes of Health.
Arends J, Strasser F, Gonella S, et al. Cancer Cachexia in Adult Patients: European Society for Medical Oncology Clinical Practice Guidelines. ESMO Open. 2021;6(3):100092. doi:10.1016/j.esmoop.2021.100092.
Clinical and Regulatory Note
This article is intended for professional education, general information and scientific discussion. It does not provide individualized cancer advice, establish a clinical treatment protocol, authorize professional practice or replace medical assessment, screening, oncology treatment, supportive care, rehabilitation or palliative care.
Lifestyle interventions should never independently delay, interrupt, replace or alter clinically indicated cancer treatment. Decisions about cancer diagnosis, staging, systemic treatment, radiotherapy, surgery, treatment toxicity and other regulated clinical activities must remain within the responsibilities of appropriately qualified and authorized healthcare professionals and facilities.
Nutrition, physical activity, psychological and other supportive interventions during or after cancer treatment should be individualized according to cancer type, stage, treatment, symptoms, nutritional status, functional capacity, comorbidities and patient preferences.
People experiencing unintended weight loss, suspected malnutrition, fever during chemotherapy, possible infection, significant treatment-related adverse effects or other concerning clinical changes should seek timely assessment through their treating healthcare team or appropriate emergency services.
The Vietnam Lifestyle Medicine Alliance is a physician-led professional platform supporting evidence-based Lifestyle Medicine through education, scientific knowledge exchange and collaboration. It is not a licensed cancer-treatment provider and does not independently deliver oncology diagnosis, anticancer treatment or individualized clinical supportive care.
International clinical guidelines and scientific publications are cited for educational purposes. Their inclusion does not mean that they automatically have regulatory force in Viet Nam or that professional education or certification expands an individual's legally authorized clinical scope.
Vietnam Lifestyle Medicine Alliance
Evidence-Based Lifestyle Medicine for Viet Nam.
Contact
contact@vlma.org
Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC
+84 909 228 476
+84 84 9999 911
© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.
A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.
VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.
VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.
VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.
